NCT05096663 2026-05-18Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)SWOG Cancer Research NetworkPhase 2/3 Active not recruiting82 enrolled